Merck & Co Inc logo

Merck & Co Inc

XTER:6MK (USA)  
€ 92.70 (-0.64%) Nov 27
On watch
56.49
P/B:
6.25
Market Cap:
€ 234.95B ($ 257.28B)
Enterprise V:
€ 258.80B ($ 283.40B)
Volume:
1.00K
Avg Vol (2M):
1.20K
Also Trade In:
Volume:
1.00K
Avg Vol (2M):
1.20K

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Financials (Next Earnings Date:2024-02-02 Est.)

XTER:6MK's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 55,420.077
EPS (TTM) (€) 1.725
Beta 0.21
Volatility % 15.64
14-Day RSI 37.85
14-Day ATR (€) 1.522334
20-Day SMA (€) 95.18
12-1 Month Momentum % -5.62
52-Week Range (€) 92.4 - 109.4
Shares Outstanding (Mil) 2,534.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price(€)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(XTER:6MK)'s stock price today?
The current price of XTER:6MK is €92.70. The 52 week high of XTER:6MK is €109.40 and 52 week low is €92.40.
When is next earnings date of Merck & Co Inc(XTER:6MK)?
The next earnings date of Merck & Co Inc(XTER:6MK) is 2024-02-02 Est..
Does Merck & Co Inc(XTER:6MK) pay dividends? If so, how much?
The  Dividend Yield %  of Merck & Co Inc(XTER:6MK) is 2.93% (As of Today), Highest Dividend Payout Ratio of Merck & Co Inc(XTER:6MK) was 1.62. The lowest was 0.37. And the median was 0.49. The  Forward Dividend Yield % of Merck & Co Inc(XTER:6MK) is 2.99%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release